COFCO Biotechnology Co., Ltd.

SZSE:000930.SZ

6.55 (CNY) • At close October 26, 2023
Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002200120001999199819971996
Revenue 20,289.83619,918.05123,468.55319,909.35119,471.95517,703.936,275.9145,603.3756,457.2837,153.1977,339.8647,730.3727,401.2935,967.1945,011.0114,801.8684,178.1464,398.1743,261.3142,198.2471,547.3581,199.416853.171705.181482.901345.643229.005102.2
Cost of Revenue 19,341.43617,666.58320,842.84917,827.69616,735.50514,803.4525,596.5094,830.8256,482.2476,463.16,652.6726,955.5176,695.0785,758.5184,752.3714,864.9234,471.0444,424.5642,921.9521,807.1531,260.874954.233660.064503.914381.836268.808169.53969.481
Gross Profit 948.42,251.4682,625.7042,081.6552,736.452,900.479679.405772.549-24.964690.097687.192774.855706.214208.676258.64-63.055-292.898-26.39339.362391.094286.485245.184193.107201.267101.06576.83559.46632.719
Gross Profit Ratio 0.0470.1130.1120.1050.1410.1640.1080.138-0.0040.0960.0940.10.0950.0350.052-0.013-0.07-0.0060.1040.1780.1850.2040.2260.2850.2090.2220.260.32
Reseach & Development Expenses 161.937132.863119.277113.67387.15196.26727.00818.5156.96313.49914.11214.45718.88820.8900000000000000
General & Administrative Expenses 124.937147.568153.909129.233179.402217.909100.683147.29876.40550.42247.86773.16591.21970.064250.45278.273207.85254.792101.67183.9446.53750.70235.50838.24616.95310.8479.7925.879
Selling & Marketing Expenses 203.47197.647220.397217.0131,121.691,135.056197.603226.708238.001216.509207.799242.161226.457187.487157.606141.482142.763172.72289.19671.5848.72437.97634.30734.05522.89613.6817.6773.102
SG&A 707.686345.215374.306346.2461,301.0911,352.965298.286374.006314.406266.932255.666315.326317.676257.551408.056419.755350.613427.514190.867155.52195.26188.67869.81472.30139.84824.52817.4698.982
Other Expenses -534.20575.028259.028400.08-258.233.919104.166215.85876.804119.662201.996367.981652.782891.25871.517871.341819.429324.364214.32913.2931.9835.95319.1123.2520.7561.080.0440.058
Operating Expenses 1,403.828553.106752.611859.9981,130.0121,516.294297.047607.306587.989604.084636.238668.096597.73517.687437.624429.474361.497438.897208.874158.00796.86989.66275.88577.26542.29325.81318.1689.631
Operating Income -455.4281,350.1561,926.6271,195.4951,656.409614.227154.924-57.807-1,547.649-57.096-143.974-96.757-144.226-557.714-539.823-802.778-780.018-687.88926.892159.179146.552133.54102.66999.31447.25241.82634.57918.978
Operating Income Ratio -0.0220.0680.0820.060.0850.0350.025-0.01-0.24-0.008-0.02-0.013-0.019-0.093-0.108-0.167-0.187-0.1560.0080.0720.0950.1110.120.1410.0980.1210.1510.186
Total Other Income Expenses Net -84.259.732-543.51-393.545-990.075-766.382-123.268-29.358-861.106-26.2873.188158.282389.752640.352502.937561.092693.807125.72380.351-83.84-48.2165.0911.218-24.158-11.154-8.117-6.912-4.067
Income Before Tax -539.6781,359.8881,383.117801.95666.334617.802259.09135.885-1,474.05959.72654.142265.041498.236331.341323.95368.56339.412-351.544226.03160.859144.966165.053120.111101.20547.81342.90534.50519.029
Income Before Tax Ratio -0.0270.0680.0590.040.0340.0350.0410.024-0.2280.0080.0070.0340.0670.0560.0650.0140.009-0.080.0690.0730.0940.1380.1410.1440.0990.1240.1510.186
Income Tax Expense 73.752298.949250.084173.754107.462100.4349.4262.64420.89428.1353.66963.578136.89359.94344.07834.72222.15130.87470.1953.78640.350.95510.13315.1817.1726.4365.1762.854
Net Income -601.631,058.5291,129.603593.117592.821483.043237.307127.079-1,418.03735.23250.718182.988355.074263.883251.92126.40325.759-384.841139.064101.13798.796110.174109.97886.02540.64136.46929.32916.175
Net Income Ratio -0.030.0530.0480.030.030.0270.0380.023-0.220.0050.0070.0240.0480.0440.050.0050.006-0.0880.0430.0460.0640.0920.1290.1220.0840.1060.1280.158
EPS -0.330.570.610.320.320.260.50.13-1.470.0370.0530.190.370.310.260.0560.027-0.40.140.130.130.140.140.130.0640.0430.0340.019
EPS Diluted -0.330.570.610.320.320.260.50.13-1.470.0370.0530.190.370.310.260.0560.027-0.40.140.130.130.140.140.130.0640.0430.0340.019
EBITDA 53.7782,238.8092,372.9161,631.8922,081.6911,994.227669.157557.912-276.036481.675498.618716.9871,012.273825.899966.423600.26596.923175.989550.051385.904281.458255.228184.854155.76373.93555.61941.29823.088
EBITDA Ratio 0.0030.1120.1010.0820.1070.1130.1070.1-0.0430.0670.0680.0930.1370.1380.1930.1250.1430.040.1690.1760.1820.2130.2170.2210.1530.1610.180.226